CL2015003413A1 - Stable formulation comprising iduronate-2-sulfatase protein and a polysorbate surfactant; container comprising said formulation; use of said formulation to treat hunters syndrome. - Google Patents
Stable formulation comprising iduronate-2-sulfatase protein and a polysorbate surfactant; container comprising said formulation; use of said formulation to treat hunters syndrome.Info
- Publication number
- CL2015003413A1 CL2015003413A1 CL2015003413A CL2015003413A CL2015003413A1 CL 2015003413 A1 CL2015003413 A1 CL 2015003413A1 CL 2015003413 A CL2015003413 A CL 2015003413A CL 2015003413 A CL2015003413 A CL 2015003413A CL 2015003413 A1 CL2015003413 A1 CL 2015003413A1
- Authority
- CL
- Chile
- Prior art keywords
- formulation
- treat
- iduronate
- container
- polysorbate surfactant
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
FORMULACIÓN ESTABLE PARA ADMINISTRACIÓN INTRATECAL QUE COMPRENDE LA PROTEÍNA IDURONATO-2-SULFATASA (I2S) Y POLISORBATO, LA CUAL ES ÚTIL PARA TRATAR SÍNDROME DE HUNTERS (DIVISIONAL DE SOL. N° 3657-12).STABLE FORMULATION FOR INTRATECAL ADMINISTRATION THAT INCLUDES PROTEIN IDURONATE-2-SULFATASE (I2S) AND POLYSORBATE, WHICH IS USEFUL TO TREAT HUNTERS SYNDROME (SOL DIVISION No. 3657-12).
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44211501P | 2001-02-11 | 2001-02-11 | |
US35885710P | 2010-06-25 | 2010-06-25 | |
US36078610P | 2010-07-01 | 2010-07-01 | |
US38786210P | 2010-09-29 | 2010-09-29 | |
US201161435710P | 2011-01-24 | 2011-01-24 | |
US201161476210P | 2011-04-15 | 2011-04-15 | |
US201161495268P | 2011-06-09 | 2011-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015003413A1 true CL2015003413A1 (en) | 2016-05-27 |
Family
ID=56081085
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015003221A CL2015003221A1 (en) | 2001-02-11 | 2015-11-02 | Stable pharmaceutical formulation for intrathecal administration comprising an arylsufatase (loop) protein, salt and a polysorbate surfactant and / or a buffering agent, and which may also contain a stabilizing agent; container comprising said formulation; use to treat metachromatic leukodystrophy (mld) disease |
CL2015003413A CL2015003413A1 (en) | 2001-02-11 | 2015-11-20 | Stable formulation comprising iduronate-2-sulfatase protein and a polysorbate surfactant; container comprising said formulation; use of said formulation to treat hunters syndrome. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015003221A CL2015003221A1 (en) | 2001-02-11 | 2015-11-02 | Stable pharmaceutical formulation for intrathecal administration comprising an arylsufatase (loop) protein, salt and a polysorbate surfactant and / or a buffering agent, and which may also contain a stabilizing agent; container comprising said formulation; use to treat metachromatic leukodystrophy (mld) disease |
Country Status (1)
Country | Link |
---|---|
CL (2) | CL2015003221A1 (en) |
-
2015
- 2015-11-02 CL CL2015003221A patent/CL2015003221A1/en unknown
- 2015-11-20 CL CL2015003413A patent/CL2015003413A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CL2015003221A1 (en) | 2016-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400730A1 (en) | CONTROLLED DOSE INHALER | |
CO5660273A2 (en) | PROTEIN AND HIGH CONCENTRATION ANTIBODY FORMULATIONS | |
CL2004000224A1 (en) | STABLE PHARMACEUTICAL FORMULATION THAT INCLUDES AN IMMUNOGLOBULIN, A PHOSPHATE TAMPON, A POLYSORBATE AND SODIUM CHLORIDE, METHOD OF PREPARATION AND ITS USE. | |
AR029139A1 (en) | STABILIZED INTERLEUQUINA 2 | |
AR025925A1 (en) | A COMPOSITION FOR A CHILD FORMULATION, A METHOD TO PRODUCE IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT OR A NUTRITIONAL PRODUCT DIRECTED TO MALNUTRITION. | |
ATE382057T1 (en) | STABLE FORMULATION OF MODIFIED GLP-1 | |
CY1108532T1 (en) | UNIONS AND COMPOSITIONS FOR PROVIDING ACTIVE AGENTS | |
ECSP034895A (en) | PHARMACEUTICAL COMPOSITIONS OF AMORFO DRUG ADSORBATES | |
RS49907B (en) | Storable active substance concentrate with formoterol | |
NO995367L (en) | Activated Vitamin D3 emulsion type solutions | |
CR7614A (en) | INSULIN ACID PREPARATIONS WITH IMPROVED STABILITY | |
NO994409D0 (en) | Stabilization of acid-sensitive benzimidazoles with amino acid / cyclodextrin combinations | |
CL2011001406A1 (en) | "Stable liquid pharmaceutical formulation comprising an antibody to il-1beta (acz885), mannitol, histidine buffer and polysorbate 80, with a pH between 5.5-7.0". | |
NO20024221L (en) | Mixtures containing alpha-2-adrenergic agonist components | |
HN2002000247A (en) | SULFONAMIDE DERIVATIVES | |
DK1259226T3 (en) | Anesthetic formulations | |
CY1107819T1 (en) | PHARMACEUTICAL FORM OF OLANZAPIN | |
SE9800729D0 (en) | New topical formulation I | |
ES2192070T3 (en) | FORMULATION OF CONCENTRATION IN SUSPENSION WITH CONTENT IN PYRIMETHANIL. | |
PT1414467E (en) | TOP TREATMENT OF MASTALGIA | |
BR0209155A (en) | Pharmaceutical tablet having a high api content | |
CL2015003413A1 (en) | Stable formulation comprising iduronate-2-sulfatase protein and a polysorbate surfactant; container comprising said formulation; use of said formulation to treat hunters syndrome. | |
IT1299264B1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SKIN DISEASES ON AN INFLAMMATORY, IMMUNE OR PROLIFERATIVE BASIS | |
DK1063969T3 (en) | Topical oil-in-water formulation as a carrier to produce a reduced irritant effect | |
SE9904132D0 (en) | Pharmaceutical composition for treatment of diarrhea |